ÖZCAN, M. Et Al. 2020. A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm. 2020 American Society of Clinical Oncology (ASCO) Annual Meeting .

ÖZCAN, M., KOYUN, D., CENGİZ SEVAL, G., USLU, A., KIRCALİ, E., ÖZTÜRK, C., ... CİVRİZ BOZDAĞ, S.(2020). A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm . 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

ÖZCAN, Et Al. "A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm," 2020 American Society of Clinical Oncology (ASCO) Annual Meeting, 2020

ÖZCAN, OSMAN Et Al. "A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm." 2020 American Society of Clinical Oncology (ASCO) Annual Meeting , 2020

ÖZCAN, M. Et Al. (2020) . "A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm." 2020 American Society of Clinical Oncology (ASCO) Annual Meeting .

@conferencepaper{conferencepaper, author={ OSMAN İLHAN Et Al. }, title={A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm}, congress name={2020 American Society of Clinical Oncology (ASCO) Annual Meeting}, city={}, country={}, year={2020}}